BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 31379858)

  • 1. Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.
    Wang X; Xia Y
    Front Immunol; 2019; 10():1667. PubMed ID: 31379858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus.
    Putterman C
    Autoimmun Rev; 2004 Feb; 3(2):7-11. PubMed ID: 15003182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis.
    Rekvig OP
    Front Immunol; 2020; 11():569234. PubMed ID: 33123142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and serological associations of autoantibodies in patients with systemic lupus erythematosus.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Ríos-Fernández R; Martín-Amada M; Cruz-Caparrós MG; Rueda-Medina B; Ortego-Centeno N
    J Investig Med; 2021 Dec; 69(8):1417-1425. PubMed ID: 34183445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies.
    Wang Y; Xiao S; Xia Y; Wang H
    Clin Rev Allergy Immunol; 2022 Oct; 63(2):152-165. PubMed ID: 34542806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.
    Sohrabian A; Parodis I; Carlströmer-Berthén N; Frodlund M; Jönsen A; Zickert A; Sjöwall C; Bengtsson AA; Gunnarsson I; Rönnelid J
    Arthritis Res Ther; 2019 Nov; 21(1):259. PubMed ID: 31783909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus.
    Diamond B; Bloom O; Al Abed Y; Kowal C; Huerta PT; Volpe BT
    J Intern Med; 2011 Jan; 269(1):36-44. PubMed ID: 21158976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-NMDA receptor antibody in systemic lupus erythematosus].
    Gono T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):225-30. PubMed ID: 25069262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of hydroxyl radical DNA cleavage by serum anti-dsDNA antibodies in SLE.
    Watanabe N; Kubota T; Miyasaka N; Kanai Y
    Lupus; 1998; 7(2):108-12. PubMed ID: 9541095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
    Rai R; Chauhan SK; Singh VV; Rai M; Rai G
    PLoS One; 2016; 11(11):e0166312. PubMed ID: 27835693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells.
    Zhang J; Jacobi AM; Wang T; Diamond B
    Mol Med; 2008; 14(11-12):675-81. PubMed ID: 18677426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus.
    Lai KN; Leung JC; Lai KB; Wong KC; Lai CK
    Clin Immunol Immunopathol; 1996 Dec; 81(3):229-38. PubMed ID: 8938099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus.
    Sun Y; Fong KY; Chung MC; Yao ZJ
    Int Immunol; 2001 Feb; 13(2):223-32. PubMed ID: 11157855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity against nucleosomes and lupus nephritis.
    Van Bruggen MC; Kramers C; Berden JH
    Ann Med Interne (Paris); 1996; 147(7):485-9. PubMed ID: 9092359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.